FO
FT Options Portfolio holdings
AUM
$40M
This Quarter Return
+1.27%
1 Year Return
+13.03%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$40M
AUM Growth
+$40M
(-1.7%)
Cap. Flow
+$38.6K
Cap. Flow
% of AUM
0.1%
Top 10 Holdings %
Top 10 Hldgs %
49.37%
Holding
144
New
32
Increased
8
Reduced
21
Closed
23
Top Buys
| 1 |
Incyte
INCY
|
$3.26M |
| 2 |
Teva Pharmaceuticals
TEVA
|
$2.3M |
| 3 |
Puma Biotechnology
PBYI
|
$1.37M |
| 4 |
Children's Place
PLCE
|
$1.3M |
| 5 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
$1.18M |
Top Sells
| 1 |
General Mills
GIS
|
$2.38M |
| 2 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$2.31M |
| 3 |
Amgen
AMGN
|
$2.08M |
| 4 |
Abbott
ABT
|
$1.83M |
| 5 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$1.62M |
Sector Composition
| 1 | Healthcare | 69.4% |
| 2 | Consumer Discretionary | 11.79% |
| 3 | Consumer Staples | 10.38% |
| 4 | Communication Services | 1.65% |
| 5 | Materials | 0.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Insmed
INSM
$28.8B
| $560K | 0.84% |
17,953
-5
| -0% | -$156 |
|
27
Regeneron Pharmaceuticals
REGN
$61.5B
| $559K | 0.84% |
1,250
+591
| +90% | +$264K |
|
|
SIOX
28
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $514K | 0.77% |
74,670
+64,861
| +661% | +$446K |
|
29
Restaurant Brands International
QSR
$20.8B
| $505K | 0.76% |
+7,900
| New | +$505K |
|
30
AbbVie
ABBV
$372B
| $480K | 0.72% |
+5,403
| New | +$480K |
|
|
CASC
31
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $471K | 0.71% |
115,206
-12,223
| -10% | -$50K |
|
32
Esperion Therapeutics
ESPR
$448M
| $442K | 0.67% |
+8,825
| New | +$442K |
|
33
Walmart
WMT
$774B
| $391K | 0.59% |
+5,000
| New | +$391K |
|
34
Clorox
CLX
$14.5B
| $317K | 0.48% |
2,400
-7,223
| -75% | -$954K |
|
35
PTC Therapeutics
PTCT
$3.92B
| $287K | 0.43% |
+14,323
| New | +$287K |
|
|
36
General Mills
GIS
$26.4B
| $259K | 0.39% |
5,000
-45,896
| -90% | -$2.38M |
|
|
AERI
37
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $246K | 0.37% |
5,060
+685
| +16% | +$33.3K |
|
|
ARAV
38
DELISTED
Aravive, Inc. Common Stock
ARAV
| $224K | 0.34% |
+91,440
| New | +$224K |
|
|
LUMO
39
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $212K | 0.32% |
+20,796
| New | +$212K |
|
40
uniQure
QURE
$896M
| $207K | 0.31% |
21,597
-20,337
| -48% | -$195K |
|
|
SAGE
41
DELISTED
Sage Therapeutics
SAGE
| $184K | 0.28% |
2,957
-6,873
| -70% | -$428K |
|
42
Kellanova
K
$27.6B
| $175K | 0.26% |
2,800
-15,178
| -84% | -$949K |
|
|
NBRV
43
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| $164K | 0.25% |
20,000
+4,880
| +32% | +$40K |
|
|
LJPC
44
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $159K | 0.24% |
+4,560
| New | +$159K |
|
45
Kraft Heinz
KHC
$33.1B
| $155K | 0.23% |
+2,000
| New | +$155K |
|
|
OTIC
46
DELISTED
Otonomy, Inc.
OTIC
| $147K | 0.22% |
45,101
-13,306
| -23% | -$43.4K |
|
|
ZYNE
47
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $146K | 0.22% |
17,500
+15,000
| +600% | +$125K |
|
48
Foot Locker
FL
$2.36B
| $141K | 0.21% |
+4,000
| New | +$141K |
|
49
VanEck Gold Miners ETF
GDX
$19B
| $132K | 0.2% |
+5,765
| New | +$132K |
|
50
DexCom
DXCM
$29.5B
| $122K | 0.18% |
+2,500
| New | +$122K |
|